NEW YORK (GenomeWeb News) – Data-mining software firm Compumine said last week that it has licensed its Rule Discovery System product to AstraZeneca in Sweden.
 
AstraZeneca will use the technology “to improve compound selection throughout its chemistry domains,” the company said in a statement.
 
Niklas Blomberg, associate director of computational chemistry at AstraZeneca, said in a statement that the software enables his team to predict “important safety and physical-chemical properties of our compounds.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.